Papers
2
Total Citations
66
H-Index
2
About
Xiaopei Chao is a leading clinical researcher in gynecologic oncology, with a primary focus on optimizing surgical treatments for early-stage cervical cancer. Her work critically addresses the global debate over the safety and efficacy of minimally invasive surgery (MIS) versus traditional open approaches. Dr. Chao is the principal investigator or key contributor to landmark, multicenter randomized controlled trials in China. Notably, she leads a phase III trial (2019) comparing different surgical approaches for early-stage cervical cancer, a direct response to the controversial LACC trial findings. Her research has garnered over 66 citations, reflecting its high clinical relevance. She is also pioneering investigations into minimally invasive versus open radical trachelectomy, a fertility-sparing procedure, aiming to balance oncologic safety with reproductive outcomes. By designing rigorous, prospective protocols, Dr. Chao is providing much-needed, high-level evidence to guide surgical decision-making in China and globally. Her work is instrumental in shaping modern standards of care, ensuring that surgical innovation does not compromise patient survival.
Research Focus
Key Achievements
Top Papers
- 1
- 2